Disparity between Solid-Organ Supply and Demand

Abstract
More patients die awaiting solid-organ transplantation than currently receive viable organs. Perhaps a victim of its own success, transplantation is the treatment of choice for failed organ function. Despite the burgeoning demand for transplanted organs, the number of available cadaveric organs has remained essentially static over the past decade. As a result, the waiting list for renal transplants in the United States has grown to more than 52,000 patients, with average waiting times exceeding 1000 days.In this issue of the Journal, Sheehy et al.1 tackle the critical issue of the shortage of cadaveric donors, attempt to ascertain where the . . .